Is a home UVB lamp covered by insurance?

Vitiligo: We found no national public UHC home-device rule for vitiligo. UHC’s Medicare Advantage list needs prior approval for codes E0692–E0694 only when the purchase or total rental cost passes $1,000. E0691 is not on that list. The lack of a national rule is not an approval or exclusion.

Psoriasis: We found no national public UHC commercial home-device rule for psoriasis. UHC’s Medicare Advantage list needs prior approval for codes E0692–E0694 only when the purchase or total rental cost passes $1,000. E0691 is not on that list. The lack of a national rule is not an approval or exclusion.

We found no national public UHC home-device rule for vitiligo. UHC’s Medicare Advantage list needs prior approval for codes E0692–E0694 only when the purchase or total rental cost passes $1,000. E0691 is not on that list. The lack of a national rule is not an approval or exclusion.

We found no national public UHC commercial home-device rule for psoriasis. UHC’s Medicare Advantage list needs prior approval for codes E0692–E0694 only when the purchase or total rental cost passes $1,000. E0691 is not on that list. The lack of a national rule is not an approval or exclusion.

Vitiligo: Anthem says home UVB may meet its vitiligo rule when creams alone have not worked. Guideline CG-DME-41 also requires doctor supervision, scheduled exams, and an expected long-term need.

Psoriasis: Anthem says home UVB may meet its psoriasis rule when creams alone have not worked. Guideline CG-DME-41 also requires doctor supervision and scheduled exams. Treatment must be expected to continue for at least three months.

Anthem says home UVB may meet its vitiligo rule when creams alone have not worked. Guideline CG-DME-41 also requires doctor supervision, scheduled exams, and an expected long-term need.

Anthem says home UVB may meet its psoriasis rule when creams alone have not worked. Guideline CG-DME-41 also requires doctor supervision and scheduled exams. Treatment must be expected to continue for at least three months.

Vitiligo: Aetna says office or home narrowband UVB may meet its vitiligo rule after a listed treatment does not work well enough. That rule is in clinical policy bulletin (CPB) 0422. It also requires a continuation review after six months.

Psoriasis: Aetna may cover prescription-only home UVB equipment for severe psoriasis with frequent flares. The rule applies when clinic access is not workable or prompt home care is needed. It appears in clinical policy bulletin (CPB) 0205.

Aetna says office or home narrowband UVB may meet its vitiligo rule after a listed treatment does not work well enough. That rule is in clinical policy bulletin (CPB) 0422. It also requires a continuation review after six months.

Aetna may cover prescription-only home UVB equipment for severe psoriasis with frequent flares. The rule applies when clinic access is not workable or prompt home care is needed. It appears in clinical policy bulletin (CPB) 0205.

Vitiligo: Cigna reported removing its home-phototherapy coverage statements because the associated codes were no longer clinically managed. That does not mean the device is automatically covered or excluded.

Psoriasis: Cigna reported removing its home-phototherapy coverage statements because the associated codes were no longer clinically managed. That statement is not a coverage approval or exclusion.

Cigna reported removing its home-phototherapy coverage statements because the associated codes were no longer clinically managed. That does not mean the device is automatically covered or excluded.

Cigna reported removing its home-phototherapy coverage statements because the associated codes were no longer clinically managed. That statement is not a coverage approval or exclusion.

Vitiligo: Humana requires prior authorization for common home ultraviolet equipment codes on its current Medicare Advantage list. That list includes Dual Eligible Special Needs Plans (D-SNPs) for people with both Medicare and Medicaid. We found no national public vitiligo-specific medical rule.

Psoriasis: Humana requires prior authorization for common ultraviolet equipment codes on its current Medicare Advantage list. That list includes Dual Eligible Special Needs Plans (D-SNPs) for people with both Medicare and Medicaid. We found no national public psoriasis-specific medical rule.

Humana requires prior authorization for common home ultraviolet equipment codes on its current Medicare Advantage list. That list includes Dual Eligible Special Needs Plans (D-SNPs) for people with both Medicare and Medicaid. We found no national public vitiligo-specific medical rule.

Humana requires prior authorization for common ultraviolet equipment codes on its current Medicare Advantage list. That list includes Dual Eligible Special Needs Plans (D-SNPs) for people with both Medicare and Medicaid. We found no national public psoriasis-specific medical rule.

Vitiligo: Kaiser Mid-Atlantic publishes vitiligo treatment rules and a separate home UVB policy. It requires doctor supervision, follow-up, ongoing need, ability to use the device, and inability to attend clinic treatment.

Psoriasis: Kaiser Mid-Atlantic includes psoriasis in a regional home UVB policy. It requires doctor supervision, follow-up, ability to use the device, ongoing need, and inability to attend clinic care.

Kaiser Mid-Atlantic publishes vitiligo treatment rules and a separate home UVB policy. It requires doctor supervision, follow-up, ongoing need, ability to use the device, and inability to attend clinic treatment.

Kaiser Mid-Atlantic includes psoriasis in a regional home UVB policy. It requires doctor supervision, follow-up, ability to use the device, ongoing need, and inability to attend clinic care.

Vitiligo: Centene’s corporate DME policy CP.MP.107 covers home ultraviolet panel lights for stubborn psoriasis, not vitiligo. No Centene or Ambetter home-UVB vitiligo rule was located. A plan may use plan-specific or licensed clinical criteria instead.

Psoriasis: Centene publishes corporate DME policy CP.MP.107, and some Ambetter plans adopt it; confirm whether your exact plan does. The policy says home ultraviolet panel lights may qualify for psoriasis that has not responded to other treatment. Records must show why treatment must happen at home. The least-cost suitable device must be chosen.

Centene’s corporate DME policy CP.MP.107 covers home ultraviolet panel lights for stubborn psoriasis, not vitiligo. No Centene or Ambetter home-UVB vitiligo rule was located. A plan may use plan-specific or licensed clinical criteria instead.

Centene publishes corporate DME policy CP.MP.107, and some Ambetter plans adopt it; confirm whether your exact plan does. The policy says home ultraviolet panel lights may qualify for psoriasis that has not responded to other treatment. Records must show why treatment must happen at home. The least-cost suitable device must be chosen.

Vitiligo: Molina’s Ohio Medicaid policy MCP-292 lists vitiligo among conditions where light therapy may qualify. Home UVB may be covered under a doctor’s direction after documented problems with standard care. Clinic care must be unworkable, or long travel, over about 45 minutes one way, must be a barrier.

Psoriasis: Molina does publish home UVB criteria, and psoriasis is one of the conditions they cover. Treatment has to be under a doctor’s direction. The criteria are written for people who cannot be treated in an office, or who find frequent visits hard to manage. The copy we can retrieve is Molina of Ohio’s Medicaid version, so read it as that plan’s, not as a national rule.

Molina’s Ohio Medicaid policy MCP-292 lists vitiligo among conditions where light therapy may qualify. Home UVB may be covered under a doctor’s direction after documented problems with standard care. Clinic care must be unworkable, or long travel, over about 45 minutes one way, must be a barrier.

Molina does publish home UVB criteria, and psoriasis is one of the conditions they cover. Treatment has to be under a doctor’s direction. The criteria are written for people who cannot be treated in an office, or who find frequent visits hard to manage. The copy we can retrieve is Molina of Ohio’s Medicaid version, so read it as that plan’s, not as a national rule.

Vitiligo: Premera’s Individual Plan may cover home UVB for severe, extensive vitiligo that has not responded to other treatment. Its prescription, device, records, safety, access, and treatment-area rules must also be met.

Psoriasis: No. Blue Cross Blue Shield of Rhode Island states that home phototherapy for skin conditions, including psoriasis, is not covered. The Massachusetts policy is not independently verified - check your plan documents. Check independent Blue plans and the Federal Employee Program (FEPBlue) separately.

Premera’s Individual Plan may cover home UVB for severe, extensive vitiligo that has not responded to other treatment. Its prescription, device, records, safety, access, and treatment-area rules must also be met.

No. Blue Cross Blue Shield of Rhode Island states that home phototherapy for skin conditions, including psoriasis, is not covered. The Massachusetts policy is not independently verified - check your plan documents. Check independent Blue plans and the Federal Employee Program (FEPBlue) separately.

Vitiligo: We found no national Medicare home NB-UVB rule for vitiligo. Medicare’s psoriasis national coverage determination (NCD) should not be applied to vitiligo. A billing code alone does not establish coverage.

Psoriasis: Medicare may cover an ultraviolet cabinet for selected people with widespread psoriasis that has not responded to other treatment. Its national coverage determination (NCD 280.1) requires the contractor to find that medical and other factors support home treatment.

We found no national Medicare home NB-UVB rule for vitiligo. Medicare’s psoriasis national coverage determination (NCD) should not be applied to vitiligo. A billing code alone does not establish coverage.

Medicare may cover an ultraviolet cabinet for selected people with widespread psoriasis that has not responded to other treatment. Its national coverage determination (NCD 280.1) requires the contractor to find that medical and other factors support home treatment.

Vitiligo: TRICARE publishes general DME requirements, but its public pages do not address home phototherapy devices at all. The public DME rule gives the contractor only the rent-or-buy choice. How a vitiligo device request is handled is not independently verified - check your plan documents.

Psoriasis: TRICARE publishes general DME requirements, but its public pages do not address home phototherapy devices at all. The public DME rule gives the contractor only the rent-or-buy choice. How a psoriasis device request is handled is not independently verified - check your plan documents.

TRICARE publishes general DME requirements, but its public pages do not address home phototherapy devices at all. The public DME rule gives the contractor only the rent-or-buy choice. How a vitiligo device request is handled is not independently verified - check your plan documents.

TRICARE publishes general DME requirements, but its public pages do not address home phototherapy devices at all. The public DME rule gives the contractor only the rent-or-buy choice. How a psoriasis device request is handled is not independently verified - check your plan documents.